EU drugs agency publishes its first report on the medical use of cannabis

, section EMCDDA news

Drug policy: medical use of cannabis in Europe 04.12.2018  What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue regulated in the EU? These and other questions are explored in a new report published today by the EU drugs agency (EMCDDA): Medical use of cannabis and cannabinoids: questions and answers for policymaking.